Search - tctmd.com

Displaying 1 - 20 of 99

Sort: Relevancy | Date

Presentation EuroPCR 2025

Final seven-year outcome of the COMPARE-ABSORB trial

Presenter: Pieter Smits

May 22, 2025

Presentation TCT 2024

TCT 915: Predictors of Conduction System Disturbances Resulting in a New Permanent Pacemaker Implantation Within the LANDMARK Trial

Presenter: Pieter Smits

October 30, 2024

Presentation TCT 2024

Future Metallic Drug Eluting Stents: New Designs, Platforms, and Components

Presenter: Pieter Smits

October 30, 2024

Presentation TCT 2024

TCT 130: Conduction Disturbances and Permanent Pacemaker Implantation After Myval Transcatheter Heart Valve or Contemporary Standard Valves (Sapien and Evolut) Implantation: LANDMARK Trial

Presenter: Pieter Smits

October 29, 2024

Presentation TCT 2023

Beyond LDL

Presenter: Pieter Smits

October 26, 2023

Presentation TCT 2023

The Primary Endpoint Results from the COMPARE 60/80 HBR Trial: A Randomized Controlled Multi-Center Trial Comparing Ultrathin With Thin Strut Stents in High Bleeding Risk Patients With an Abbreviated DAPT Duration

Presenter: Pieter Smits

October 25, 2023

Presentation TCT 2022

Does It Matter What Stent I Use in a HBR Patient?

Presenter: Pieter Smits

September 18, 2022

Presentation TCT 2021

Case-Based Learning: Managing Non-culprit Lesions in the STEMI Patient With Coronary Physiology

Presenter: Pieter Smits

November 06, 2021

Presentation TCT 2021

MASTER-DAPT: A Randomized Trial of Abbreviated Antiplatelet Therapy - Outcomes in High Bleeding Risk Patients With High Thrombotic and Ischemic Risk

Presenter: Pieter Smits

November 05, 2021

Presentation TCT 2019

Not So Fast: There Is So Much More to Learn!

Presenter: Pieter Smits

September 26, 2019

Presentation TCT 2018

COMPARE ABSORB: A Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in High-Risk and Complex Lesions

Presenter: Felix Mahfoud, Patrick W. Serruys, Pieter C. Smits

September 25, 2018

Presentation TCT 2018

Case Presentation #2: A High-Risk, Complex Patient With STEMI and Multivessel Disease

Presenter: Anthony H. Gershlick, Pieter C. Smits, Marwan F. Jumean

September 24, 2018

Presentation TCT 2018

Flash Debate #1: Based on What We Dont Know - Culprit Lesion Only PCI With a Conservative Approach Is the Preferred Strategy!

Presenter: Anthony H. Gershlick, Pieter C. Smits, Deepak L. Bhatt

September 24, 2018

Presentation TCT 2018

Flash Debate #1: Based on What We Know - Routine Multivessel Revascularization (Acute or Delayed) Is the Preferred Strategy!

Presenter: Anthony H. Gershlick, Pieter C. Smits, Thomas Engstrøm

September 24, 2018

Presentation TCT 2018

The Role of FFR, iFR, and iMR in Assessing Non-Culprit Lesions and Vessels in STEMI

Presenter: Anthony H. Gershlick, Pieter C. Smits, Joo Myung Lee

September 24, 2018

Presentation TCT 2018

Management of Non-Culprit CTO in STEMI

Presenter: Anthony H. Gershlick, Pieter C. Smits, Emmanouil S. Brilakis

September 24, 2018

Presentation TCT 2018

Rationale and Data for Multivessel PCI in STEMI

Presenter: Anthony H. Gershlick, Pieter C. Smits

September 24, 2018

Presentation TCT 2018

Flash Debate: Polymeric BRS Have the Edge!

Presenter: Pieter C. Smits

September 22, 2018

Presentation TCT 2018

MVD Case Presentation With Heart Team Discussion, Case Introduction

Presenter: Antonio Colombo, Jeffrey W. Moses, Carlos Collet, Pablo Lamelas, John D. Puskas, Alfredo E. Rodriguez, Pieter C. Smits, Wilson Y. Szeto

September 22, 2018

Presentation CIT 2018

FFR Guided PCI in STEMI patients with Multivessel Disease

Presenter: Pieter C. Smits

March 23, 2018

Advertisement

Final seven-year outcome of the COMPARE-ABSORB trial

TCT 915: Predictors of Conduction System Disturbances Resulting in a New Permanent Pacemaker Implantation Within the LANDMARK Trial

Future Metallic Drug Eluting Stents: New Designs, Platforms, and Components

TCT 130: Conduction Disturbances and Permanent Pacemaker Implantation After Myval Transcatheter Heart Valve or Contemporary Standard Valves (Sapien and Evolut) Implantation: LANDMARK Trial

Beyond LDL

The Primary Endpoint Results from the COMPARE 60/80 HBR Trial: A Randomized Controlled Multi-Center Trial Comparing Ultrathin With Thin Strut Stents in High Bleeding Risk Patients With an Abbreviated DAPT Duration

Does It Matter What Stent I Use in a HBR Patient?

Case-Based Learning: Managing Non-culprit Lesions in the STEMI Patient With Coronary Physiology

MASTER-DAPT: A Randomized Trial of Abbreviated Antiplatelet Therapy - Outcomes in High Bleeding Risk Patients With High Thrombotic and Ischemic Risk

Not So Fast: There Is So Much More to Learn!

COMPARE ABSORB: A Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in High-Risk and Complex Lesions

Case Presentation #2: A High-Risk, Complex Patient With STEMI and Multivessel Disease

Flash Debate #1: Based on What We Dont Know - Culprit Lesion Only PCI With a Conservative Approach Is the Preferred Strategy!

Flash Debate #1: Based on What We Know - Routine Multivessel Revascularization (Acute or Delayed) Is the Preferred Strategy!

The Role of FFR, iFR, and iMR in Assessing Non-Culprit Lesions and Vessels in STEMI

Management of Non-Culprit CTO in STEMI

Rationale and Data for Multivessel PCI in STEMI

Flash Debate: Polymeric BRS Have the Edge!

MVD Case Presentation With Heart Team Discussion, Case Introduction

FFR Guided PCI in STEMI patients with Multivessel Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content